Walter Jentzen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Walter Jentzen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- James Nagarajah
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
2 shared publications Andreas Bockisch
Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany
1 shared publication- Andreas Bockisch
Klinik für Nuklearmedizin, Universitätsklinikum Essen
1 shared publication - Andreas Bockisch
Klinik für Nuklearmedizin, Universitätsklinikum Essen, Universitätsklinikum der Universität Duisburg-Essen, Essen, Deutschland
1 shared publication - Ernst Günter Eising
Clinic for Nuclear Medicine, University of Duisburg/Essen, Germany
1 shared publication Ina Binse
Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany
1 shared publication
Latest Publications
- 1 October 2019
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 63 (3) , 235-252
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
Radioiodine therapy of thyroid cancer was the first successful radionuclide therapy in the treatments of cancer, although its clinical use is empirical and not based on precise dosimetry. 124I is a positron-emitting radionuclide and positron emission tomography/computed tomography (PET/CT) with 124I currently provides the most accurate estimation of the absorbed (radiation) dose to thyroid cancer lesions. In the application, serial 124I PET/CT scans are performed to determine the time uptake curves and to delineate the volumes of the lesions. The 124I data are then used to project the absorbed dose per unit administered 131I activity. The results are part of the decision-making process to individually guide treatment plans, in particular by tailoring the therapeutic 131I activity in radioiodine therapy. The aim of this review is to provide an overview of 124I PET/CT lesion dosimetry of differentiated thyroid cancer including: 1) an historical overview; 2) the general properties of 124I and its activity measurement; 3) the main factors impairing PET image quantification; 4) an optimized lesion dosimetry protocol used in our group to make this manuscript self-contained; as well as 5) a summary of important clinical studies.
- 1 October 2019
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 63 (3) , 235-252
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
Radioiodine therapy of thyroid cancer was the first successful radionuclide therapy in the treatments of cancer, although its clinical use is empirical and not based on precise dosimetry. 124I is a positron-emitting radionuclide and positron emission tomography/computed tomography (PET/CT) with 124I currently provides the most accurate estimation of the absorbed (radiation) dose to thyroid cancer lesions. In the application, serial 124I PET/CT scans are performed to determine the time uptake curves and to delineate the volumes of the lesions. The 124I data are then used to project the absorbed dose per unit administered 131I activity. The results are part of the decision-making process to individually guide treatment plans, in particular by tailoring the therapeutic 131I activity in radioiodine therapy. The aim of this review is to provide an overview of 124I PET/CT lesion dosimetry of differentiated thyroid cancer including: 1) an historical overview; 2) the general properties of 124I and its activity measurement; 3) the main factors impairing PET image quantification; 4) an optimized lesion dosimetry protocol used in our group to make this manuscript self-contained; as well as 5) a summary of important clinical studies.
- 9 January 2019
- Published by Springer Nature
- p. 199-204
Imaging of Differentiated Thyroid Cancer with Iodine-124 and F-18-FDG
- 9 January 2019
- Published by Springer Nature
- p. 199-204
Imaging of Differentiated Thyroid Cancer with Iodine-124 and F-18-FDG
- Open Access
- 7 September 2016
- Published by IntechOpen
124I PET: Pretherapeutic Staging, Detection of Recurrent Thyroid Cancer and Dosimetry
- 7 September 2016
- Published by IntechOpen
Open Access124I PET: Pretherapeutic Staging, Detection of Recurrent Thyroid Cancer and Dosimetry
- 8 June 2016
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 55 (12) , 6294-6299
Metalloporphines: Dimers and Trimers
Procedures for the purification and subsequent crystallization of the slightly soluble four-coordinate metallporphines, the simplest possible porphyrin derivatives, are described. Crystals of the porphine derivatives of cobalt(II), copper(II), platinum(II), and two polymorphs of zinc(II) were obtained. Analysis of the crystal and molecular structures shows that all except the platinum(II) derivative form an unusual trimeric species in the solid state. The isomorphous cobalt(II), copper(II), and one zinc(II) polymorph pack in the unit cell to form dimers as well as the trimers. Interplanar spacings between porphine rings are similar in both the dimers and trimers and range between 3.24 and 3.37 Å. Porphine rings are strongly overlapped with lateral shifts between ring centers in both the dimers and trimers with values between 1.52 and 1.70 Å or in Category S as originally defined by Scheidt and Lee. Periodic trends in the M–Np bond distances parallel those observed previously for tetraphenyl- and octaethylporphyrin derivatives.
- 8 June 2016
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 55 (12) , 6294-6299
Metalloporphines: Dimers and Trimers
Procedures for the purification and subsequent crystallization of the slightly soluble four-coordinate metallporphines, the simplest possible porphyrin derivatives, are described. Crystals of the porphine derivatives of cobalt(II), copper(II), platinum(II), and two polymorphs of zinc(II) were obtained. Analysis of the crystal and molecular structures shows that all except the platinum(II) derivative form an unusual trimeric species in the solid state. The isomorphous cobalt(II), copper(II), and one zinc(II) polymorph pack in the unit cell to form dimers as well as the trimers. Interplanar spacings between porphine rings are similar in both the dimers and trimers and range between 3.24 and 3.37 Å. Porphine rings are strongly overlapped with lateral shifts between ring centers in both the dimers and trimers with values between 1.52 and 1.70 Å or in Category S as originally defined by Scheidt and Lee. Periodic trends in the M–Np bond distances parallel those observed previously for tetraphenyl- and octaethylporphyrin derivatives.
- 31 August 2007
- Published by Elsevier in Academic Radiology
- Vol. 14 (8) , 967-973
Economic Image Compression of Output Documentation of the Most Frequent Examinations in Nuclear Medicine
- 31 August 2007
- Published by Elsevier in Academic Radiology
- Vol. 14 (8) , 967-973
Economic Image Compression of Output Documentation of the Most Frequent Examinations in Nuclear Medicine